Guardant Health Inc

27 de out. de 2026, 20:07 UTC

BTIG analyst Mark Massaro raised the price target on Guardant Health to $210 from $195, maintaining a Buy rating due to strong growth prospects.

26 de out. de 2026, 20:07 UTC

Guardant Health Inc is advancing today, reflecting a notable gain since Friday's close, with the stock remaining above its 20-day moving average.

22 de out. de 2026, 20:07 UTC

Guardant Health Inc shares are declining, reaching a low point around midday and closing significantly below Wednesday's close, remaining below its 20-day moving average.

21 de out. de 2026, 19:56 UTC

Guardant Health Inc shares are advancing, having earlier reached a peak before retracing, currently trading below the 20-day moving average.

20 de out. de 2026, 20:08 UTC

Guardant Health Inc will present 25 abstracts at the ESMO Congress 2026, focusing on advancements in circulating tumor DNA monitoring across various cancer types.

19 de out. de 2026, 20:07 UTC

Guardant Health Inc shares are lower amid legal pressures from a U.S. patent ruling affecting its Duplex Sequencing technology and recent test data release.

16 de out. de 2026, 20:02 UTC

Guardant Health Inc shares are declining following a recent loss in a DNA sequencing patent challenge against TwinStrand, marking its second setback in ongoing disputes.

15 de out. de 2026, 19:41 UTC

Guardant Health presents new data at the American College of Gastroenterology meeting, highlighting the effectiveness of its blood-based testing for colorectal cancer screening.

14 de out. de 2026, 19:31 UTC

Guardant Health Inc is rising amid a notable increase in the Health Care Services sector, with unusually high market volume today.

12 de out. de 2026, 20:07 UTC

Guardant Health Inc shares are declining, continuing a downward trend from Friday's close, reaching a session low before stabilizing near the lower end of its one-month range.

8 de out. de 2026, 20:07 UTC

Guardant Health Inc shares are declining amid a broader market downturn, reflecting ongoing pressures from rising mortgage rates and credit condition concerns.

7 de out. de 2026, 20:07 UTC

Shares of Guardant Health Inc declined despite Barclays raising the price target to $220.00 from $200.00, finishing significantly below their 20-day moving average.

6 de out. de 2026, 23:05 UTC

Guardant Health Inc is trading modestly lower in after-hours action, continuing a downward trend since Tuesday's close and remaining below its 20-day moving average.

5 de out. de 2026, 23:45 UTC

Guardant Health Inc's shares advanced in after-market hours, recovering from earlier declines and remaining significantly above the 20-day moving average.

2 de out. de 2026, 20:07 UTC

Guardant Health Inc is advancing amid a broadly higher market, supported by declining U.S. Treasury yields and recent labor statistics indicating potential economic challenges.

1 de out. de 2026, 19:15 UTC

Guardant Health Inc shares fell sharply after reaching an early high, hitting a low before 2 PM, though still above its 20-day moving average.

30 de set. de 2026, 20:07 UTC

Guardant Health Inc is advancing during Wednesday's session, regaining ground after pulling back earlier, and remains above its 20-day moving average.

28 de set. de 2026, 19:16 UTC

Guardant Health's Shield blood test is now covered for about 70 million Americans, yet shares are declining amid fluctuating trading activity.

24 de set. de 2026, 19:35 UTC

Shares of Guardant Health Inc are trading lower despite social media attention on its new blood test for detecting common cancers, emphasizing early detection.

22 de set. de 2026, 19:55 UTC

Guardant Health Inc shares are higher, reflecting positive trading activity and reaching a peak return earlier in the session, while remaining above its 20-day moving average.

21 de set. de 2026, 23:06 UTC

Guardant Health Inc saw modest gains in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

18 de set. de 2026, 22:11 UTC

Guardant Health Inc is gaining in after-market trading, reaching a peak return and remaining significantly above its 20-day moving average.

17 de set. de 2026, 19:56 UTC

Guardant Health Inc is trading sharply higher, reaching its highest cumulative return since Wednesday and well above its 20-day moving average.

16 de set. de 2026, 19:16 UTC

Guardant Health Inc is trading roughly flat, maintaining a slight range and positioned near the upper end of its one-month trading range.

15 de set. de 2026, 23:31 UTC

Guardant Health Inc shares are lower in after-market hours, continuing a decline since Tuesday's close, with no specific news identified to explain the movement.

14 de set. de 2026, 20:02 UTC

Guardant Health Inc shares are higher today, driven by unusually high trading volume, despite broader market concerns over rising crude oil prices and inflation.

11 de set. de 2026, 20:08 UTC

Guardant Health Inc shares are lower today, continuing a trend since Thursday's close. The stock is trading below its 20-day moving average.

10 de set. de 2026, 20:07 UTC

Guardant Health Inc shares are lower today, reflecting broader market declines. The stock peaked earlier but has since reached a session low.

8 de set. de 2026, 20:08 UTC

Guardant Health recognized by Business Insider for innovation in biotechnology. Shares are lower today, pulling back from earlier session highs.

4 de set. de 2026, 20:02 UTC

Guardant Health Inc shares are lower today, extending a decline over three sessions. High trading volume accompanies the move amid unchanged unemployment data.